Top analysts on stock perps · Analyst
Geoff Meacham (Citi): analyst track record on stock perps
Geoff Meacham of Citi on companies with stock perpetual futures: star rating, success rate, price-target accuracy, current calls and the measured perp reaction after each rating.
Stars4.8★
Success58%
Excess return+14.3%
rank#401
Ratings480
ratings on stock perps495
Track record
TipRanks data via FMP| 12 months | 3 years | |
|---|---|---|
| Ratings | 312 | 648 |
| Stock | 48 | 60 |
| Buy / hold / sell | 169 / 133 / 10 | 358 / 270 / 20 |
| Upgrades / downgrades / initiations | 0 / 4 / 7 | 2 / 9 / 24 |
| Price targets hit / missed | 155 / 152 (50%) | 399 / 222 (64%) |
| Avg. return after a rating (TipRanks) | +16.6% | +30.7% |
| Best / worst call | +626.3% / -73.6% | +674.0% / -98.3% |
After buy calls: median 21-day move +1.6% · vs S&P 500 +0.3% (n = 191) · targets hit within a year 54% (n = 120)
Current calls on stock perps
| Stock | Call | Target | vs last close | Date |
|---|---|---|---|---|
| $AMGN Amgen Inc. | Hold · Maintained | $405 | -7.8% | Oct 26, 2026 |
| $BNTX BioNTech SE | Buy · Maintained | $125 | +41.9% | Oct 26, 2026 |
| $MRNA Moderna, Inc. | Sell · Maintained | $80.00 | -60.0% | Oct 26, 2026 |
| $ABBV AbbVie Inc. | Hold · Maintained | $260 | -9.0% | Oct 20, 2026 |
| $LLY Eli Lilly and Company | Buy · Maintained | $1,600 | +25.6% | Oct 20, 2026 |
| $VRTX Vertex Pharmaceuticals | Buy · Maintained | $585 | +11.7% | Oct 19, 2026 |
| $MRK Merck & Co., Inc. | Hold · Maintained | $145 | -0.2% | Oct 16, 2026 |
| $BMY Bristol Myers Squibb | Hold · Maintained | $70.00 | +13.9% | Oct 13, 2026 |
| $PFE Pfizer Inc. | Hold · Maintained | $27.00 | -10.1% | Oct 13, 2026 |
| $BIIB Biogen Inc. | Hold · Maintained | $215 | -14.2% | Oct 12, 2026 |
| $GILD Gilead Sciences, Inc. | Buy · Maintained | $165 | +5.7% | Oct 12, 2026 |
| $REGN Regeneron Pharmaceuticals, Inc. | Hold · Maintained | $740 | -8.1% | Oct 12, 2026 |
Recent ratings
- Oct 26, 2026 $AMGN: Maintained · Hold · $405 · article
- Oct 26, 2026 $BNTX: Maintained · Buy · $125 · article
- Oct 26, 2026 $MRNA: Maintained · Sell · $80.00 · article
- Oct 26, 2026 $AMGN: Maintained · Hold · $405
- Oct 22, 2026 $MRNA: Maintained · Sell · $80.00 · article
- Oct 23, 2026 $MRNA: Maintained · Sell · $80.00 · article
- Oct 22, 2026 $MRNA: Maintained · Sell · $80.00
- Oct 21, 2026 $AMGN: Maintained · Hold · $405 · article
- Oct 21, 2026 $AMGN: Maintained · Hold · $405
- Oct 20, 2026 $LLY: Maintained · Buy · $1,600 · article
- Oct 20, 2026 $ABBV: Maintained · Hold · $260 · article
- Oct 19, 2026 $BNTX: Maintained · Buy · $125 · article
- Oct 20, 2026 $ABBV: Maintained · Hold · $260
- Oct 19, 2026 $BNTX: Maintained · Buy · $125
- Oct 19, 2026 $VRTX: Maintained · Buy · $585 · article
- Oct 19, 2026 $VRTX: Maintained · Buy · $585
- Oct 16, 2026 $MRK: Maintained · Hold · $145 · article
- Oct 15, 2026 $MRNA: Maintained · Sell · $80.00 · article
- Oct 15, 2026 $MRNA: Maintained · Sell · $80.00
- Oct 13, 2026 $BNTX: Maintained · Buy · $125 · article
Geoff Meacham4.8★ · 58% success · +14.3% excess return · TipRanks data via FMP · Source headlines via TheFly/StreetInsider (FMP). Reaction = venue-median perp move after our detection — an observation, not investment advice.